LAZARD ASSET MANAGEMENT LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1207017
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,338,451
-$48,833,065 QoQ
Shares Held
93,287
-56.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#178
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names. VRTX ranks #2 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,338,451 | 93,287 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $95,171,516 | 213,131 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $90,195,972 | 198,950 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $213,374,479 | 544,823 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $213,834,012 | 480,310 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $258,213,676 | 532,597 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $211,868,119 | 526,119 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,714,593 | 7,987 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $57,397,575 | 122,456 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $51,784,331 | 123,883 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $48,740,945 | 119,789 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $41,365,758 | 118,956 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,129,255 | 119,716 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $40,180,875 | 127,530 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $41,134,110 | 142,441 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $180,626,922 | 623,841 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $243,440,070 | 863,906 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $234,309,824 | 897,842 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $201,092,111 | 915,720 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $30,099,130 | 165,936 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $28,579,237 | 141,741 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $24,902,527 | 115,885 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $31,222,640 | 132,109 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $56,106,245 | 206,182 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $58,126,739 | 200,223 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $13,949,342 | 58,623 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||